Aker Biomarine AS risk profile
57 Elevated one input has moved against it
Measured 1 September 2026 from AKBM's filed statements. Recomputed nightly.
57 (Elevated), driven by Cash conversion at 86, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 28 | Normal | Stable | One-year price volatility — 33.9% |
| Operating pressure | 44 | Elevated | Stable | Operating-margin drift — -2.1 percentage points |
| Cash conversion | 86 | Acute | Stable | Capital spending against operating cash — 2.17x |
| Leverage and coverage | 60 | Stretched | Stable | Net debt to EBITDA — 5.05x |
| Competitive position | 62 | Stretched | Stable | Revenue-growth gap against peers — -34.5 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.
Consumer Defensive companies with a risk reading
Walmart Inc 43Costco Wholesale Corp 40Coca-Cola Company 30Procter & Gamble Company 34Philip Morris International Inc 24Nestle S.A. 45Nestlé S.A 45L'Oréal S.A. 32PepsiCo Inc 43Anheuser-Busch InBev SA/NV 35Unilever plc 42Unilever PLC 42
Financials, valuation and price history for Aker Biomarine AS